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Summary Single time point assessment is usually employed in the Human Tumour Cloning System as the
only parameter for in vitro growth. This does not seem to give a fair expression of the dynamic biological
properties of tumour growth and time dependent effects, e.g. of cytotoxic drugs. We studied the time course
of colony formation in temporal growth patterns (TGPs) and compared this method of growth evaluation
with conventional single time point assessment in 57 samples of ovarian tumour cultures in the HTCS. A first
advantage of the use of TGPs is that more cultures become evaluable, as this assessment over time can detect
a rise in the number of colonies in dishes where colony-like clumps have initially been seeded. Thus only 28
of the cultures were evaluable for single time point assessment, whereas 57 were available for TGP evaluation.
Growth was more often seen at TGP evaluation (14/57) than at single day assessment (8/57). Evaluation of
growth over the course of time potentially allows detection of sensitivity to drugs. Furthermore TGPs reflect
the dynamics of biological growth. These features cannot be studied in single time point assessment.
The, Human Tumour Cloning System (HTCS)
(Hamburger & Salmon, 1977) was introduced as a
chemosensitivity test for individual patient's
tumours, especially in ovarian cancer (Alberts et al.,
1980; Von Hoff et al., 1980; Ozols et al., 1980).
Also, an application in the detection of persisting
viable tumour following therapy has been
advocated (Herman et al., 1983a, Verheijen et al.,
1984).
A weak point in this test is the definition of in
vitro tumour cell growth, which has always been
based on variable criteria without much rationale:
more than 5-30 colonies (Cowan & Von Hoff,
1983; Salmon, 1980) after 7-29 days in culture
(Alberts et al., 1980; Williams et al., 1983)
constitutes growth. Colonies are defined as clusters
of cells with a minimum diameter of 60 gm and/or
containing at least 20-30 cells (Kern et al., 1982;
Von Hoff et al., 1981). In vitro drug effects are
measured as a decrease or increase of the number
of colonies at only one specific time point as
compared with control growth.
Assessment of growth, based on single day
colony counts, ignores the fact that colony
development of different tumours under different
conditions may follow different patterns of
temporal growth (Kirkels et al., 1983). Counting
colonies in the dishes frequently over a period of
time provides valuable information on the processes
of soft agar colony growth that are missed in the
usual growth determination.
This study reports on the additional information
in the assessment of time course of colony
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formation that may be obtained beyond colony
counts at a single time point.
Materials and methods
Tumour material
Ovarian carcinoma cells were obtained from solid
tumours, ascites or peritoneal washings from 25
patients with histologically proven ovarian
carcinoma. Twenty-two of 25 patients suffered from
Stage III or IV disease. Twenty-four of the 25
patients had an epithelial tumour, one patient had
a granulosa cell tumour.
A total of 57 samples were obtained from these
25 patients. Growth assessment was done for
samples that were plated immediately after
reception (43 samples) as well as for samples that
were plated after incubation in a water bath with
McCoy's Wash (Gibco, Paisley, Scotland) as a
control in chemosensitivity tests (14 samples). Thus
57 temporal growth patterns were available for
growth assessment for non-drug treated cultures.
All cultures that were not lost due to infection were
eligible for this study.
Culture method
All material was cultured in a double layer soft
agar culture system as described in detail by
Hamburger & Salmon (1980). In brief, tumour
tissue was minced and incubated with collagenase
Type II (1,000-1,500Uml-1; Worthington, Free-
hold, NJ, USA) and DNase Type I (100-150
KunitzUml-1; Sigma, St Louis, Mo) for 2h at
37°C, washed with McCoy's wash, sieved through a
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150-200gm metal sieve and further through a 70-
100gm nylon sieve and a 25 gauge needle. Cells
from effusions were not treated enzymatically but
were resuspended in McCoy's wash after
centrifugation. Of the cell suspension, 0.1ml was
counted in a Burker-Tiirk haemocytometer. The cell
concentration was adjusted to 3 x 106 cellsml-
McCoy's wash.
For in vitro drug tests with adriamycin and cis-
platin, cells were incubated for 1 h in drug solutions
made up in McCoy's wash to 10% of the in vivo
attainable peak plasma level. The cells for the
control groups were incubated with McCoy's wash
alone, omitting the cytostatic drug.
Plastic 35mm petri dishes were seeded with
5 x 105 nucleated cells in double-enriched CMRL-
1066 (Gibco, Paisley, Scotland) with 0.3% agar
over a bottom feeder layer of enriched McCoy's
medium with 0.5% agar, as described by
Hamburger & Salmon (1980), except that
conditioned medium and mercaptoethanol were not
used.
Growth assessment
Eighteen to 24 dishes were plated from each sample
to allow frequent colony counting without having
to return the counted dishes to the incubator,
thereby reducing the risk of infection. Colonies
were counted with an automated colony counter
(OmniconTM, Bausch & Lomb Inc., Rochester, NY,
USA), the operating characteristics of which have
been published elsewhere (Herman et al., 1983b).
Briefly, this instrument accepts as colonies round,
relatively dense, homogeneous objects >60p4m in
diameter and counts these objects in 6 size
categories. Sixty microns is the cut-off point
adopted by all users of the automated colony
counter until now.
One point evaluation: day 21 counts Single point
colony counts were performed on pairs of dishes
after a period used by many authors of 20 to 22
days in culture (further called 'Day 21 counts').
Cultures with a mean of 30 colonies or more per
dish were considered as positive for in vitro growth.
However, when >30 structures were counted by
the OmniconTm on Day 1, reflecting cell clumps
seeded, cultures were regarded as not evaluable for
in vitro growth by Day 21 counts.
Dynamic evaluation: temporal growth patterns
Temporal growth patterns (TGPs or growth curves)
were obtained by counting pairs of dishes at
intervals of 2 to 3 days for 4-6 weeks. As a
criterion for growth a minimum of 30 colonies had
to be reached. Furthermore, the increase had to be
consistent over 3 consecutive counts and an
arbitrary cut-off point was used of 100% increase
in the number of structures/colonies counted, either
after the initial first day count or after a fall in the
growth curve, reflecting deterioration of seeded
clumps.
In addition to the number of colonies at peak
growth the number of days in which peak growth
was reached was calculated from the time of
plating.
Results
All 57 cultures were evaluable for TGPs while only
28 cultures were evaluable by Day 21 counts. This
lower number in the latter evaluation method is due
to high Day 1 counts, indicating the presence of cell
clumps at the start of the culture period, which
makes them non-evaluable at a later stage. Data
obtained from both methods of growth assessment
are compared in Table I. In 23 out of 28 (82%) of
the cases evaluable by both methods, the two types
of evaluation gave the same results as to the
presence or absence of growth.
At Day 21, 8 samples showed >30 colonies.
Thus, by single day assessment growth was
detectable in 14% of all cultures, and in 35% of the
evaluable cultures.
When assessed by temporal growth patterns, 14
cultures, i.e. 25% of all cultures, met the criteria for
growth. In 6 cases growth assessed in this way
corresponded with >30 colonies at Day 21.
In 2 cases of 'positive' Day 21 counts but
negative growth curves, temporal growth patterns
showed marginal fluctuation around 30 colonies
resulting in just <30 'colonies' on Day 1 and just
>30 'colonies' counted on Day 20. However, there
was no consistent increase in the number of
colonies counted over time.
On the other hand, in 3 cases where growth was
seen in the growth curves, Day 21 evaluation was
negative with <30 colonies counted. One sample
showed early peak growth at 12 days in culture.
Two other samples showed late growth after the
21st day in culture.
Notably 5 of the 14 cultures positive for growth
according to the temporal growth pattern were not
evaluable by Day 21 evaluation due to seeding of
clumps.
The mean time to reach peak growth for ovarian
carcinomas in this study was 19.8 days with a wide
range of 8-37 days.
In addition, growth in soft agar was assessed
after preincubation of the tumour cells with
adriamycin and cis-platinum (Table II). The present
data compare only presence or absence of colony
growth as assessed by Day 21 counts versusGROWTH CURVES IN SOFT AGAR CULTURE
Table I Comparison of the two methods of in vitro growth assessment: for temporal growth patterns and
single day counts the number of growth positive, growth negative, and not evaluable samples are
compared. Not evaluable specimens by single day counts are those with >30 cell clumps counted on
Day 1.
Evaluation ofin vitro growth by
temporal growth pattern
No Not
Growth growth evaluable Totals
Evaluation of in vitro Growth 6 2 0 8
growth by No growth 3 17 0 20
single day counts Not evaluable 5 24 0 29
Totals 14 43 0 57
Table II Growth in control cultures and cultures preincubated with
adriamycin (ADR) and cis-platin (DDP) as assessed with single time point
Day 21 counts (D21) and in temporal growth patterns (TGP) for ovarian
carcinoma. Note that differences in amount of growth are not depicted. Thus
assessment of in vitro chemosensitivity cannot be inferred from these data (see
Discussion)
Control ADR DDP
Sample number D21 TGP D21 TGP D21 TGP
1 NE - - - - -
2 + + + + + +
3 NE - NE - + +
4 + - + - _ _
5 - - _ - - _
6 NE - NE - NE -
7 - - _ - _ _
8 + - _ - _ _
9 - - _ _ - _
10 NE + infected infected
11 + + + + + +
12 - - - - - _
13 - - - - - _
14 NE - NT NT NE -
NE=not evaluable; + =growth;-=no growth; NT=not tested.
temporal growth patterns. Data analysis techniques
for determination of in vitro chemosensitivity using
temporal growth patterns are being developed.
Many curves are lost to evaluation in single day
growth assessment. Similar numbers of growth
positive curves are obtained in both methods of
growth evaluation (10 vs 8 for Day 21 and TGP
growth assessment respectively).
In Figure 1 a control curve and a curve obtained
from a drug (adriamycin) treated culture of an
ovarian carcinoma are shown. Evaluation of the
culture on the basis of single point assessment after
a period of 21 days, would have shown a
stimulation of 240% for adriamycin. Only in the
TGP can a delay in peak growth be appreciated. In
this case growth after incubation with cis-platin is
equal to control growth.
A second chemosensitivity test (Figure 2) shows a
persistent reduction in the number of colonies after
adriamycin incubation. Again, the number of
colonies attains a similar level as the control curve
after incubation with cis-platin, but after a marked
lag time which cannot be detected by single time
point assessment.
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Figure 1 Temporal growth patterns in soft agar culture of an ovarian carcinoma: control culture (-), and
after I h incubation with adriamycin (- -) and cis-platin (....). Adriamycin effect is seen as an early relative
inhibition with subsequent 'catch up'. Cis-platin has no effect on the temporal growth pattern initially,
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Figure 2 Temporal growth patterns of soft agar culture of an ovarian carcinoma in a control culture (-)
and after incubation with adriamycin (--) and cis-platin (....). This tumour sample showed markedly less
growth with adriamycin, whereas cis-platin showed early inhibition of growth with 'catch-up' to control
colony number by 30 days. Each point represents mean +s.e. as computed by the automated colony counter.
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Discussion
Growth of tumour cell colonies in soft agar is
commonly determined on the basis of the presence
of a minimum number of 'colony like structures'
after a fixed period of culture. In chemosensitivity
testing especially, this approach is not entirely
satisfactory because one has to rely on the outcome
of only one observation that may not be
representative of dynamic tumour cell growth.
It is argued that the pattern of growth is not a
constant feature of any tumour type or specimen.
Not only the number of colonies grown after a
certain period of time, but also growth rate, lag
time before growth commences, time required for
peak growth, and total number of colonies formed
may be intrinsic properties unique for each tumour
which can be variably influenced by culture
conditions and cytotoxic drugs.
These mechanisms may explain why some
patients respond to chemotherapy with agents that,
by Day 21 evaluation, were not regarded as active
in vitro and vice versa. Excellent in vitro - in vivo
correlation when single time point evaluation was
used have been reported (Von Hoff et al., 1983).
This correlation, however, only regards the
predictive value for resistance. As the sensitivity of
this assay is - 60% (Alberts et al., 1980) it is
unacceptable as a routine laboratory test for
chemosensitivity.
Use of TGPs has three potential advantages.
Firstly, evaluation of the time course of colony
growth reflects the biologic quality of in vitro
growth. Two other features concern the quantative
evaluability of cultures. TGP evaluation may allow
assessment of sensitivity to specific drugs, where
single time point assessment fails to disclose any
effect. In this study we have only used TGPs to
assess whether there was any growth and whether
there were differences in growth pattern.
Parameters such as the slope of a curve, that can be
used in quantitative assessment of in vitro chemo-
sensitivity by means of TGP are currently under
investigation. Of course the clinical relevance of
differences observed in patterns over time can only
be concluded from a prospective study, comparable
to those performed for single time point assessment
(Von Hoff et al., 1983). Finally, more cultures
become evaluable for growth.
By the use of temporal growth patterns
essentially all cultures are evaluable for growth,
unless they are infected. Even when clumps are
initially seeded, it is still possible to evaluate the
rise or fall in 'colony-like structures' counted over
time. In single time point evaluation it is not
thought feasible to subtract the many cell
aggregates of less than colony size present in
culture (Umbach & Spitzer, 1983).
Clumps would either remain constant or
deteriorate. In the latter case, swelling of the dying
cells may cause small clumps to 'grow' and make
them detectable by automated counting. Conse-
quently, cell death would cause disaggregation
of the clumps. A decrease in the number of
colonies is often seen after an early initial increase
in the temporal growth pattern. Colonies formed in
the meantime, conversely, increase the number
counted after the fall, allowing detection of growth.
Still, additional criteria such as total area of
colonies as proposed by Thomson et al. (1984) may
prove to be useful. In the study of primary human
tumours, of often poor quality, this method may
have the disadvantage that when deterioration
occurs, swelling of the cells will cause the total area
to increase. This will not be fully corrected by the
disaggregation of the clumps, clusters or colonies.
A combination of the use of both total area and
number of 'objects' greater than a certain
biologically acceptable lower limit (e.g. 60pam)
might prove to give optimal information on in vitro
tumour cell growth.
The disadvantages in the use of TGPs are mainly
of a logistical nature. The main problem concerns
the availability of tumour material. Often small
biopsies or body fluids containing only a few
tumour cells are offered for culture. This may give
rise to problems in plating a growth test with as
many as 24 dishes used by us, and even more
frequently to problems for chemosensitivity testing
with at least 18 dishes for each drug and control.
Despite this requirement, more cultures prove to be
evaluable for growth when using temporal growth
patterns than in single time point assessment. While
it is necessary to reduce the risk of infection,
counting new dishes each time allows a fair
interpretation of the growth pattern since the
criterion of consistent increase over 3 countings is
used. Thus it is very unlikely that dish to dish
variability will be interpreted as consistent growth.
The growth positive rate of 25% as assessed by
TGPs in this study seems to be lower than reported
generally for ovarian carcinoma cultures (Williams
et al., 1983). This is explained by the rigid criteria
for colony growth used in this study as opposed to
a low threshold for colony formation of e.g. 5
colonies used in large studies (Sandbach et al.,
1982; Cowan & Von Hoff, 1983) as well as as a low
number of cells (20) for a cell aggregate to be called
a 'colony' by others (Kern et al., 1982; Bertelsen et
al., 1984; Alonso, 1984). It should be noted
especially that in the concept of TGPs it is not
enough to see a sufficient number of colonies on
any day, but that temporal increase should be
consistent and reach 100%.
The fact that the mean time to peak is 20 days
shows that Day 21 counts seems to be well timed.712 R.H.M. VERHEIJEN et al.
However, the great range in time to peak shows
that the right time for evaluation cannot be
predicted for individual cultures for single time
point assessment.
In conclusion, the use of TGPs may not make
soft agar cultures available for routine use as a
chemosensitivity test but this type of growth assess-
ment can point out sample to sample variability in
growth patterns and therefore show the right time
for evaluation, potentially with additional parameters
to conventional evaluation.
The authors wish to acknowledge the excellent technical
assistance of O.E. Gellings, A.M.M. Aalders, C.N. Verrijp
and J. Vedder.
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